CRISPR THERAPEUTICS AG

Ticker: CRSP CUSIP: H17182108 Class: NAMEN AKT

Ensign Peak Advisors, Inc's Holding History (CIK: 0001454984)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 5,314 Value ($000) $279 Avg Close $59.89 Range $48.02 - $78.48
Q3 2025
Shares 15,464 Value ($000) $1,002 Avg Close $57.41 Range $46.60 - $71.13
Q2 2025
Shares 28,464 Value ($000) $1,384 Avg Close $38.70 Range $30.04 - $51.52
Q1 2025
Shares 28,464 Value ($000) $969 Avg Close $42.39 Range $32.96 - $55.88
Q4 2024
Shares 28,464 Value ($000) $1,120 Avg Close $47.22 Range $38.20 - $59.07
Q3 2024
Shares 28,464 Value ($000) $1,337 Avg Close $50.74 Range $43.42 - $63.68
Q2 2024
Shares 28,464 Value ($000) $1,537 Avg Close $57.84 Range $51.02 - $68.39
Q1 2024
Shares 28,464 Value ($000) $1,940 Avg Close $71.59 Range $58.29 - $91.10
Q4 2023
Shares 29,900 Value ($000) $1,872 Avg Close $55.02 Range $37.55 - $76.97
Q3 2023
Shares 29,900 Value ($000) $1,357 Avg Close $51.65 Range $44.53 - $59.67
Q2 2023
Shares 29,900 Value ($000) $1,679 Avg Close $56.74 Range $43.10 - $72.00
Q1 2023
Shares 27,700 Value ($000) $1,253 Avg Close $48.57 Range $39.88 - $58.50
Q2 2022
Shares 37,169 Value ($000) $2,259 Avg Close $58.79 Range $42.51 - $75.42